Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

We aimed to evaluate the performance of the Khorana score in predicting venous
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …

PURPOSE To provide updated recommendations about prophylaxis and treatment of
venous thromboembolism (VTE) in patients with cancer. METHODS PubMed and the …

Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …

Background There is currently a lack of model for predicting the occurrence of venous
thromboembolism (VTE) in patients with lung cancer. Machine learning (ML) techniques are …

Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus,
we aimed to develop a nomogram to predict the risk of VTE in these patients. We …

Cancer-associated thrombosis (CAT) is a leading cause of death in cancer patients
receiving outpatient chemotherapy. The latest guidelines emphasize stratifying the patients …

Objectives: This study aimed to describe the longitudinal thromboembolism (TE) risk relative
to the natural history of disease and clinical course of ROS1 rearranged non-small cell lung …

Patients with cancer are at increased risk of venous thromboembolism (VTE). Risk
assessment models can help identifying high-risk populations that might benefit from …

Background Acute complications, such as venous thromboembolism (VTE), are common in
patients with advanced severe lung cancers. However, current VTE risk scores cannot …